|
GINS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.33589999752016E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.991800E-04 |
| Normal-vs-Stage2 |
4.562200E-02 |
| Normal-vs-Stage3 |
1.641140E-04 |
| Normal-vs-Stage4 |
2.700400E-02 |
| Stage1-vs-Stage2 |
7.356600E-01 |
| Stage1-vs-Stage3 |
2.580800E-03 |
| Stage1-vs-Stage4 |
1.292580E-01 |
| Stage2-vs-Stage3 |
8.261000E-03 |
| Stage2-vs-Stage4 |
3.159200E-01 |
| Stage3-vs-Stage4 |
1.063810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.31099999990082E-07 |
| Normal-vs-AfricanAmerican |
4.999600E-04 |
| Normal-vs-Asian |
1.219440E-01 |
| Caucasian-vs-AfricanAmerican |
5.288600E-01 |
| Caucasian-vs-Asian |
2.252400E-01 |
| AfricanAmerican-vs-Asian |
3.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75959999999731E-05 |
| Normal-vs-Female |
5.11019999982487E-07 |
| Male-vs-Female |
3.903400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.820840E-03 |
| Normal-vs-Extreme_Weight |
1.448090E-02 |
| Normal-vs-Obese |
4.47639999999749E-05 |
| Normal-vs-Extreme_Obese |
5.245000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.650400E-02 |
| Normal_Weight-vs-Obese |
4.399600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.182600E-01 |
| Extreme_Weight-vs-Obese |
5.901100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.073600E-01 |
| Obese-vs-Extreme_Obese |
2.913500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.456000E-03 |
| Normal-vs-Age(41-60Yrs) |
9.8686000005177E-07 |
| Normal-vs-Age(61-80Yrs) |
2.175000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.911200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.594000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.541690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.583200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.183600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.403200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.140000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.972690E-04 |
| Normal-VS-Type2 PRCC |
1.102450E-03 |
| Normal-VS-KIRP CIMP |
3.917400E-03 |
| Normal-VS-Unclassified PRCC |
5.971500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.380200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.896600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.847800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.500340E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.673400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.978300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.422700E-03 |
| Normal-vs-N1 |
6.4390999999997E-05 |
| Normal-vs-N2 |
2.751800E-01 |
| N0-vs-N1 |
1.979870E-03 |
| N0-vs-N2 |
3.685800E-01 |
| N1-vs-N2 |
3.876000E-01 |
|
|
